HIMS is hovering around $45, but demand is drying up.Buyers seem hesitant at these levels after the hype from the Novo Nordisk breakdown faded.
Without new momentum or a catalyst, we might see a correction or sideways action until confidence returns.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.